Dexmedetomidine and HIPEC

NCT04106999 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Inflammation
Cancer

Interventions

DRUG: Dexmedetomidine
DRUG: Placebos

Sponsor

University of British Columbia